Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Patriot Scientific Corporation Files Complaint against The TPL Group

<"TPL must not market patent portfolios in which PDS does not have an interest with the MMP Patent Portfolio." >

If PDS is paying all Alliacense licensing costs, PDS should be able exert complete control over what Alliacense does. No? If this were not the case, and TPL actually was billing the other portfolios properly for work done by Alliacense, could PDS make such a request?

Opty

Share
New Message
Please login to post a reply